AVANIR PHARMACEUTICALS, INC CL A
AVNR
AVNR was delisted on the 12th of January, 2015.
142 hedge funds and large institutions have $1.93B invested in AVANIR PHARMACEUTICALS, INC CL A in 2014 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 54 increasing their positions, 36 reducing their positions, and 15 closing their positions.
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
415% more call options, than puts
Call options by funds: $154M | Put options by funds: $30M
180% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 15
171% more capital invested
Capital invested by funds: $711M → $1.93B (+$1.22B)
50% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 36
23% more funds holding
Funds holding: 115 → 142 (+27)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JG
Jefferies Group
New York
|
+$49.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$47.4M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$36.8M |
| 4 |
MGM
Miura Global Management
New York
|
+$28.4M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$17.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ISL
Ingalls & Snyder LLC
New York
|
-$49.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.1M |
| 3 |
Millennium Management
New York
|
-$8.51M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.12M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.02M |
AVNR Hedge Fund Activity: Q3 2014 in Review
142 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q3 2014, worth a combined $1.93B — up 171% from $711M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new AVNR positions and 15 closed out — a net gain of 27 holders — while 54 added to existing stakes and 36 trimmed.
The largest buyer was Jefferies Group, adding an estimated $49.2M. The largest seller was Ingalls & Snyder LLC, cutting an estimated $49.8M.
- 142 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q3 2014, up from 115 in Q2 2014.
- Funds reported $1.93B of AVANIR PHARMACEUTICALS, INC CL A stock for Q3 2014, up 171% quarter-over-quarter.
- 42 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q3 2014 and 15 closed out, a net change of +27 holders.
- The largest AVANIR PHARMACEUTICALS, INC CL A buyer in Q3 2014 was Jefferies Group, an estimated $49.2M added.
- The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q3 2014 was Ingalls & Snyder LLC, an estimated $49.8M sold.
Based on aggregated 13F filings for Q3 2014.